Yuan Yuan

机构：Xuzhou Central Hospital · ORCID：0000-0002-1600-7894

发表论文 53 篇 · 总被引 1361 次 · h-index 17

代表论文

• First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial (2023 · Nature Medicine · 被引 174)
• First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial (2025 · Nature Medicine · 被引 89)
• Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer (2023 · Journal of Experimental & Clinical Cancer Research · 被引 48)
• Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation (2025 · Cell Death and Disease · 被引 32)
• A phase I/II study of ASKB589 (anti-claudin 18.2 [CLDN18.2] monoclonal antibody) in patients with solid tumors. (2023 · Journal of Clinical Oncology · 被引 13)
• Lactylation-driven NSUN2 -mediated RNA m5C modification promotes perineural invasion in pancreatic cancer (2025 · Theranostics · 被引 8)